Join PharmQD!

Become a member of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling.

Network With Peers

Join the conversation with trusted colleagues. Link up with professionals who share your ideas and insights.

Learn and Advance

Take free CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on pharmacy news.

Unite

Share your experience with pharmacy students and technicians.

Create an account and receive access to the personalized box below, including your profile, bookmarks, friends, posts and more!

Join Now!

PharmNews

Featured News

Hormone Therapy for Brain Performance: No Effect, Whether Started Early or Late - 07.21.2016

A study led by a scientist at the Stanford University School of Medicine shows that hormone therapy has a negligible effect on verbal memory and other mental skills regardless of how soon after menopause a woman begins therapy.More »

Featured News

Infections, Antibiotic Use Linked to Manic Episodes in People With Serious Mental Illness - 07.21.2016

In research using patient medical records, investigators from Johns Hopkins and Sheppard Pratt Health System report that people with serious mental disorders who were hospitalized for mania were more likely to be on antibiotics to treat active infections than a group of people without a mental disorder.More »

Featured News

Study Examines Opioid Agonist Therapy Use in Medicare Patients - 07.20.2016

Few Medicare enrollees appear to be receiving buprenorphine-naloxone, the only opioid agonist therapy for opioid addiction available through Medicare Part D prescription drug coverage, according to aMore »

Featured News

Risk of Low Blood Sugar Differs Among Similar Diabetes Drugs - 07.19.2016

A new systematic review of randomized clinical trials lasting 12 to 52 weeks found that when added to metformin, gliclazide confers the lowest risk of hypoglycemia compared with glipizide, glimepiride, and glibenclamide.More »

Featured News

New Study Shows Differences in Blood Pressure Variation Across Ethnicity - 07.14.2016

Differences in circadian blood pressure variation due to a combination of genetic and cultural factors may contribute to ethnic differences in cardiovascular morbidity, according to new research.More »

Advertisement

PharmTalk

New Blog Postings

Other Blog Posts

Ethics and the Pharmacist 04.19.15 2 comments nyrxman
Taking the Pulse of Pharmacy 03.18.15 nyrxman
Taking a "Shot" at Pharmacists? 03.07.15 2 comments michelerx1416
The Glass Is Half Full 02.18.15 1 comment nyrxman